Anika Jäkel

Anika Jäkel has had a diverse work experience in the biotechnology and research fields. Anika is currently working at Ariceum Therapeutics as a Senior Director, starting in December 2022. Prior to this, they worked at Glycotope GmbH, where they held the role of Director from April 2018 to November 2022, and before that, they were a Scientist from January 2016 to March 2018. Anika also has experience at the Robert Koch Institute, where they worked as a Postdoc from November 2011 to December 2015, and as a PhD Student from August 2007 to October 2011.

Anika Jäkel has a Diplom degree in Biology from Humboldt-Universität zu Berlin, which they obtained between the years 2002 and 2007.